Related references
Note: Only part of the references are listed.Forodesine has high antitumor activity in chronic lymphocytic leukemia and activates p53-independent mitochondrial apoptosis by induction of p73 and BIM
Roberto Alonso et al.
BLOOD (2009)
Pharmacology and mechanism of action of forodesine, a T-cell targeted agent
Varsha Gandhi et al.
SEMINARS IN ONCOLOGY (2007)
Forodesine (BCX-1777, Immucillin H) - A new purine nucleoside analogue: Mechanism of action and potential clinical application
Anna Korycka et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2007)
Forodesine, an inhibitor of purine nucleoside phosphorylase, induces apoptosis in chronic lymphocytic leukemia cells
Kumudha Balakrishnan et al.
BLOOD (2006)
A proof-of-principle pharmacokinetic, pharmacodynamic, and clinical study with purine nucleoside phosphorylase inhibitor immucillin-H (BCX-1777, forodesine)
V Gandhi et al.
BLOOD (2005)
Structural basis for inhibition of human PNP by immucillin-H
WF de Azevedo et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Crystal structure of human purine nucleoside phosphorylase complexed with acyclovir
DM dos Santos et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Mechanism of inhibition of T-acute lymphoblastic leukemia cells by PNP inhibitor - BCX-1777
S Bantia et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2003)
Intravenous and oral pharmacokinetic study of BCX-1777, a novel purine nucleoside phosphorylase transition-state inhibitor.: In vivo effects on blood 2′-deoxyguanosine in primates
JM Kilpatrick et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2003)
Development of transition state analogues of purine nucleoside phosphorylase as anti-T-cell agents
VL Schramm
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2002)
Purine nucleoside phosphorylase inhibitor BCX-1777 (immucillin-H) - a novel potent and orally active immunosuppressive agent
S Bantia et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2001)
Immucillin H, a powerful transition-state analog inhibitor of purine nucleoside phosphorylase, selectively inhibits human T lymphocytes
GA Kicska et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Pharmacokinetics and pharmacodynamics of peldesine (BCX-34), a purine nucleoside phosphorylase inhibitor, following single and multiple oral doses in healthy volunteers
TX Viegas et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2000)